Ultragenyx Pharmaceutical, Inc. (RARE)
22.49
+2.77
(+14.05%)
USD |
NASDAQ |
Dec 30, 15:00
Ultragenyx Pharmaceutical EPS Diluted (Quarterly): -1.808 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Geron Corp. | -0.0276 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Fortress Biotech, Inc. | 0.111 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -180.41M |
| Revenue (Quarterly) | 159.93M |
| Total Expenses (Quarterly) | 340.35M |
| Enterprise Value | 2.338B |
| Gross Profit Margin (Quarterly) | 77.12% |
| Profit Margin (Quarterly) | -112.8% |
| Earnings Yield | -26.41% |
| Normalized Earnings Yield | -26.37 |